2023-09206. Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches; Public Workshop; Request for Comments; Correction
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of public workshop; request for comments; correction.
SUMMARY:
The Food and Drug Administration is correcting a notice entitled “Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches” that appeared in the Federal Register of April 24, 2023. The document announced a public workshop. The document was published with an incorrect topic for discussion. This document corrects that error.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Lisa Granger, Office of Policy, Legislation, and International Affairs, Food and Drug Administration, 301–796–9115, Lisa.Granger@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In the Federal Register of April 24, 2023, in FR Doc. 2023–08545 (88 FR 24807), on page 24808, the following correction is made:
- On page 24808, in the second column, in Section II, “Topics for Discussion at the Public Workshop,” the fifth topic, “Science- and risk-based approaches for developing and accessing innovative technologies across platform products and sites to streamline adoption.” is corrected to read “Science- and risk-based approaches for developing and assessing innovative technologies across platform products and sites to streamline adoption.”
Dated: April 26, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–09206 Filed 5–1–23; 8:45 am]
BILLING CODE 4164–01–P
Document Information
- Published:
- 05/02/2023
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice of public workshop; request for comments; correction.
- Document Number:
- 2023-09206
- Pages:
- 27522-27522 (1 pages)
- Docket Numbers:
- Docket No. FDA-2023-N-1259
- PDF File:
- 2023-09206.pdf